BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 12783965)

  • 1. Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas.
    Sebire NJ; Malone M
    J Clin Pathol; 2003 Jun; 56(6):412-6. PubMed ID: 12783965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype.
    Heerema-McKenney A; Wijnaendts LC; Pulliam JF; Lopez-Terrada D; McKenney JK; Zhu S; Montgomery K; Mitchell J; Marinelli RJ; Hart AA; van de Rijn M; Linn SC
    Am J Surg Pathol; 2008 Oct; 32(10):1513-22. PubMed ID: 18708938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of a prospective minimal disseminated disease study in human rhabdomyosarcoma using three different molecular markers.
    Sartori F; Alaggio R; Zanazzo G; Garaventa A; Di Cataldo A; Carli M; Rosolen A;
    Cancer; 2006 Apr; 106(8):1766-75. PubMed ID: 16544315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhabdomyosarcoma: value of myogenin expression analysis and molecular testing in diagnosing the alveolar subtype: an analysis of 109 paraffin-embedded specimens.
    Hostein I; Andraud-Fregeville M; Guillou L; Terrier-Lacombe MJ; Deminière C; Ranchère D; Lussan C; Longavenne E; Bui NB; Delattre O; Coindre JM
    Cancer; 2004 Dec; 101(12):2817-24. PubMed ID: 15536621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.
    Cessna MH; Zhou H; Perkins SL; Tripp SR; Layfield L; Daines C; Coffin CM
    Am J Surg Pathol; 2001 Sep; 25(9):1150-7. PubMed ID: 11688574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myogenin--a more specific target for RT-PCR detection of rhabdomyosarcoma than MyoD1.
    Michelagnoli MP; Burchill SA; Cullinane C; Selby PJ; Lewis IJ
    Med Pediatr Oncol; 2003 Jan; 40(1):1-8. PubMed ID: 12426678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoradiotherapy-induced Cytodifferentiation in Bladder/Prostate Rhabdomyosarcoma With Genetic Downregulation of Myogenin and MyoD1 Gene Expression: A Case Study and Review of the Literature.
    Agard H; Clark C; Massanyi E; Steele M; McMahon D
    Urology; 2020 Mar; 137():173-177. PubMed ID: 31945380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood.
    Wang NP; Marx J; McNutt MA; Rutledge JC; Gown AM
    Am J Pathol; 1995 Dec; 147(6):1799-810. PubMed ID: 7495304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymerase chain reaction-based diagnosis of rhabdomyosarcomas: comparison of fetal type acetylcholine receptor subunits and myogenin.
    Gattenlöhner S; Müller-Hermelink HK; Marx A
    Diagn Mol Pathol; 1998 Jun; 7(3):129-34. PubMed ID: 9836066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: A single institutional experience.
    Rekhi B; Gupta C; Chinnaswamy G; Qureshi S; Vora T; Khanna N; Laskar S
    Ann Diagn Pathol; 2018 Oct; 36():50-60. PubMed ID: 30098515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the Children's Oncology Group experience.
    Morotti RA; Nicol KK; Parham DM; Teot LA; Moore J; Hayes J; Meyer W; Qualman SJ;
    Am J Surg Pathol; 2006 Aug; 30(8):962-8. PubMed ID: 16861966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of rhabdomyosarcoma masquerading as acute leukemia at presentation: a case report.
    Srinivas U; Pillai L; Kar R; Mahapatra M; Gujra S; Pati HP
    Indian J Pathol Microbiol; 2007 Oct; 50(4):917-9. PubMed ID: 18306605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma.
    Paner GP; McKenney JK; Epstein JI; Amin MB
    Am J Surg Pathol; 2008 Jul; 32(7):1022-8. PubMed ID: 18469707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embryonal rhabdomyosarcoma of the adult soft palate.
    Bhutoria S; Oneil C
    Indian J Pathol Microbiol; 2011; 54(1):136-7. PubMed ID: 21393897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhabdomyosarcoma subtyping by immunohistochemical assessment of myogenin: tissue array study and review of the literature.
    Morgenstern DA; Rees H; Sebire NJ; Shipley J; Anderson J
    Pathol Oncol Res; 2008 Sep; 14(3):233-8. PubMed ID: 18493875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of new monoclonal anti-MyoD1 and anti-myogenin antibodies for the diagnosis of rhabdomyosarcoma.
    Cui S; Hano H; Harada T; Takai S; Masui F; Ushigome S
    Pathol Int; 1999 Jan; 49(1):62-8. PubMed ID: 10227726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhabdomyosarcoma: molecular analysis of Igf2, MyoD1 and Myogenin expression.
    Krskova L; Augustinakova A; Drahokoupilova E; Sumerauer D; Mudry P; Kodet R
    Neoplasma; 2011; 58(5):415-23. PubMed ID: 21744995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic potential of the chromosome translocation t(2;13) in rhabdomyosarcoma: a Pcr study of fresh-frozen and paraffin-embedded tumour samples.
    Reichmuth C; Markus MA; Hillemanns M; Atkinson MJ; Unni KK; Saretzki G; Höfler H
    J Pathol; 1996 Sep; 180(1):50-7. PubMed ID: 8943815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical profile of myogenin and MyoD1 does not support skeletal muscle lineage in alveolar soft part sarcoma.
    Gómez JA; Amin MB; Ro JY; Linden MD; Lee MW; Zarbo RJ
    Arch Pathol Lab Med; 1999 Jun; 123(6):503-7. PubMed ID: 10383802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myogenin and desmin immunohistochemistry in the assessment of post-chemotherapy genitourinary embryonal rhabdomyosarcoma: prognostic and management implications.
    Godbole P; Outram A; Wilcox DT; Duffy PG; Sebire NJ
    J Urol; 2006 Oct; 176(4 Pt 2):1751-4. PubMed ID: 16945640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.